Understanding Phagocytosis Within the Adipose Tissue

了解脂肪组织内的吞噬作用

基本信息

  • 批准号:
    10251932
  • 负责人:
  • 金额:
    $ 3.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT On a daily basis, we turnover billions of apoptotic cells that are removed by phagocytic cells, such as macrophages. The processes of cell death and phagocytic clearance are vital to maintaining homeostasis and are related to many disease pathologies. The adipose tissue has been reported to undergo basal turnover, and during conditions of obesity, apoptotic adipocytes have been shown to increase in mice and humans. This cell death and subsequent macrophage infiltration to clear the dying cells has been described as a key inducer of inflammation and causative in the development of insulin resistance. This inflammation has been specifically attributed to macrophage activity, as depletion of macrophages reduces inflammation and improves insulin sensitivity. Interestingly, these macrophage depletion conditions do not result in the accumulation of dead cells, possibly demonstrating additional phagocytic population(s). In addition to professional phagocytes (such as macrophages), non-professional phagocytes also exist, such as epithelial cells in the digestive tract and lung, or mesenchymal cells during embryonic limb development. These non-professional phagocytes can play vital roles in maintaining homeostasis, yet in the adipose tissue no such population has been defined thus far. Based on preliminary studies, we propose to investigate specific non-professional phagocytic cell populations in the adipose tissue and define how these cells contribute to inflammation, inflammation resolution, and insulin resistance associated with obesity. PtdSer is a lipid specifically exposed on the surface of apoptotic cells and is used by phagocytic cells for clearance. To allows us to better manipulate the phagocytic activity of these cell populations, we will additionally investigate the role of phosphatidylserine (PtdSer) receptors. Understanding cell types, the phagocytic process, and molecular players during homeostasis and adipose tissue inflammation will provide important therapeutic opportunities for obesity.
项目总结/摘要 每天,我们周转数十亿个凋亡细胞,这些细胞被吞噬细胞清除,如 巨噬细胞细胞死亡和吞噬清除过程对维持体内平衡至关重要, 与许多疾病病理学有关。据报道,脂肪组织经历基础周转,并且在 在肥胖症的情况下,凋亡脂肪细胞已显示在小鼠和人中增加。这种细胞死亡和 随后巨噬细胞浸润以清除垂死细胞被描述为炎症的关键诱导物, 导致胰岛素抵抗的发展。这种炎症特别归因于巨噬细胞 活性,因为巨噬细胞的消耗减少了炎症并提高了胰岛素敏感性。有趣的是,这些 巨噬细胞耗竭条件不导致死细胞的积累,可能证明了额外的 吞噬细胞群。除了专职吞噬细胞(如巨噬细胞), 也存在吞噬细胞,例如消化道和肺中的上皮细胞,或胚胎发育期间的间充质细胞。 肢体发育这些非专职吞噬细胞在维持体内平衡方面发挥着重要作用,但在 脂肪组织迄今为止还没有定义这样的群体。根据初步研究,我们建议调查 脂肪组织中特定的非专职吞噬细胞群,并确定这些细胞如何有助于 炎症、炎症消退和与肥胖相关的胰岛素抵抗。PtdSer是一种脂质, 暴露在凋亡细胞的表面上,并被吞噬细胞用于清除。让我们更好地 操纵这些细胞群的吞噬活性,我们将另外研究 磷脂酰丝氨酸(PtdSer)受体。了解细胞类型、吞噬过程和分子参与者 在体内平衡和脂肪组织炎症期间将为肥胖提供重要的治疗机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brady Barron其他文献

Brady Barron的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brady Barron', 18)}}的其他基金

Understanding Phagocytosis Within the Adipose Tissue
了解脂肪组织内的吞噬作用
  • 批准号:
    10557389
  • 财政年份:
    2020
  • 资助金额:
    $ 3.45万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了